Detailed information for compound 1483739

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 392.415 | Formula: C21H23F3N2O2
  • H donors: 2 H acceptors: 2 LogP: 4.68 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCNC(=O)C(Cc1ccccc1C)NC(=O)c1ccc(cc1)C(F)(F)F
  • InChi: 1S/C21H23F3N2O2/c1-3-12-25-20(28)18(13-16-7-5-4-6-14(16)2)26-19(27)15-8-10-17(11-9-15)21(22,23)24/h4-11,18H,3,12-13H2,1-2H3,(H,25,28)(H,26,27)
  • InChiKey: BNQSAELPQKGBIM-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus histone acetyltransferase KAT2B 0.0043 0.1284 0.0764
Trypanosoma cruzi hypothetical protein, conserved 0.0035 0.0898 0.1666
Echinococcus granulosus histone acetyltransferase KAT2B 0.0142 0.5953 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0044 0.1342 0.0845
Brugia malayi Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative 0.0035 0.0898 0.1462
Trypanosoma cruzi hypothetical protein, conserved 0.0035 0.0898 0.1666
Trypanosoma cruzi Peptide deformylase 2, putative 0.0087 0.3358 1
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0222 0.9733 0.9707
Loa Loa (eye worm) beta-LACTamase domain containing family member 0.0035 0.0898 0.0857
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0044 0.1342 0.0845
Trypanosoma brucei hypothetical protein, conserved 0.0035 0.0898 0.1666
Trypanosoma brucei Polypeptide deformylase 1 0.0087 0.3358 1
Trypanosoma cruzi polypeptide deformylase-like protein, putative 0.0087 0.3358 1
Loa Loa (eye worm) beta-lactamase 0.0035 0.0898 0.0857
Loa Loa (eye worm) hypothetical protein 0.0035 0.0898 0.0857
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0044 0.1342 0.0845
Plasmodium vivax hypothetical protein, conserved 0.0035 0.0898 0.0513
Trypanosoma brucei Peptide deformylase 2 0.0087 0.3358 1
Trypanosoma cruzi Peptide deformylase 2, putative 0.0087 0.3358 1
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0044 0.1342 0.1629
Brugia malayi acetyltransferase, GNAT family protein 0.0146 0.6146 1
Onchocerca volvulus 0.0035 0.0898 0.5
Entamoeba histolytica acetyltransferase, GNAT family 0.0039 0.1116 0.5
Plasmodium falciparum histone acetyltransferase GCN5 0.0039 0.1116 0.0739
Treponema pallidum polypeptide deformylase (def) 0.0228 1 0.5
Wolbachia endosymbiont of Brugia malayi peptide deformylase 0.0228 1 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0044 0.1342 0.0845
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0044 0.1342 0.0877
Trichomonas vaginalis cat eye syndrome critical region protein 2, cscr2, putative 0.0043 0.1284 1
Onchocerca volvulus 0.0035 0.0898 0.5
Mycobacterium tuberculosis Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) 0.0228 1 1
Brugia malayi hypothetical protein 0.0024 0.0407 0.0662
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis 0.0146 0.6146 1
Trypanosoma cruzi polypeptide deformylase-like protein, putative 0.0087 0.3358 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.0043 0.1284 1
Mycobacterium leprae PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) 0.0228 1 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0044 0.1342 0.0877
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0044 0.1342 0.0845
Toxoplasma gondii histone lysine acetyltransferase GCN5-A 0.0043 0.1284 0.0915
Brugia malayi beta-lactamase 0.0035 0.0898 0.1462
Plasmodium vivax histone acetyltransferase GCN5, putative 0.0043 0.1284 0.0915
Leishmania major hypothetical protein, conserved 0.0035 0.0898 0.1666
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0146 0.6146 1
Onchocerca volvulus 0.0035 0.0898 0.5
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0044 0.1342 0.2183
Plasmodium falciparum peptide deformylase 0.0228 1 1
Plasmodium vivax peptide deformylase, putative 0.0228 1 1
Loa Loa (eye worm) acetyltransferase 0.0146 0.6146 1
Brugia malayi beta-lactamase family protein 0.0035 0.0898 0.1462
Loa Loa (eye worm) hypothetical protein 0.0035 0.0898 0.0857
Toxoplasma gondii ABC1 family protein 0.0035 0.0898 0.0513
Loa Loa (eye worm) hypothetical protein 0.0035 0.0898 0.0857
Toxoplasma gondii histone lysine acetyltransferase GCN5-B 0.0043 0.1284 0.0915
Giardia lamblia Histone acetyltransferase GCN5 0.0039 0.1116 0.5
Mycobacterium ulcerans peptide deformylase 0.0228 1 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.0898 0.0857
Brugia malayi beta-lactamase family protein 0.0035 0.0898 0.1462
Loa Loa (eye worm) hypothetical protein 0.0035 0.0898 0.0857
Leishmania major polypeptide deformylase-like protein, putative 0.0087 0.3358 1
Toxoplasma gondii hypothetical protein 0.0228 1 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.0898 0.0857

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 35.4813 uM PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.